1. Home
  2. CTSO vs LASE Comparison

CTSO vs LASE Comparison

Compare CTSO & LASE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CTSO
  • LASE
  • Stock Information
  • Founded
  • CTSO 1997
  • LASE 2019
  • Country
  • CTSO United States
  • LASE United States
  • Employees
  • CTSO N/A
  • LASE N/A
  • Industry
  • CTSO Medical/Dental Instruments
  • LASE Industrial Machinery/Components
  • Sector
  • CTSO Health Care
  • LASE Industrials
  • Exchange
  • CTSO Nasdaq
  • LASE Nasdaq
  • Market Cap
  • CTSO 68.2M
  • LASE 41.3M
  • IPO Year
  • CTSO N/A
  • LASE 2022
  • Fundamental
  • Price
  • CTSO $0.87
  • LASE $2.87
  • Analyst Decision
  • CTSO Strong Buy
  • LASE
  • Analyst Count
  • CTSO 3
  • LASE 0
  • Target Price
  • CTSO $4.67
  • LASE N/A
  • AVG Volume (30 Days)
  • CTSO 138.7K
  • LASE 102.2K
  • Earning Date
  • CTSO 05-14-2025
  • LASE 05-13-2025
  • Dividend Yield
  • CTSO N/A
  • LASE N/A
  • EPS Growth
  • CTSO N/A
  • LASE N/A
  • EPS
  • CTSO N/A
  • LASE N/A
  • Revenue
  • CTSO $35,594,520.00
  • LASE $3,077,760.00
  • Revenue This Year
  • CTSO $18.72
  • LASE N/A
  • Revenue Next Year
  • CTSO $19.75
  • LASE N/A
  • P/E Ratio
  • CTSO N/A
  • LASE N/A
  • Revenue Growth
  • CTSO 14.51
  • LASE 0.93
  • 52 Week Low
  • CTSO $0.70
  • LASE $1.58
  • 52 Week High
  • CTSO $1.61
  • LASE $19.80
  • Technical
  • Relative Strength Index (RSI)
  • CTSO 33.89
  • LASE 47.03
  • Support Level
  • CTSO $0.87
  • LASE $2.82
  • Resistance Level
  • CTSO $1.16
  • LASE $3.06
  • Average True Range (ATR)
  • CTSO 0.07
  • LASE 0.20
  • MACD
  • CTSO -0.02
  • LASE 0.03
  • Stochastic Oscillator
  • CTSO 0.00
  • LASE 53.53

About CTSO Cytosorbents Corporation

CytoSorbents Corp specializes in treating life-threatening conditions in intensive care and cardiac surgery using proprietary polymer adsorption technology. Its flagship product, CytoSorb, is approved in the EU as an extracorporeal cytokine absorber, aiming to reduce inflammation and prevent multiple organ failure in critical illnesses like sepsis and trauma. Revenue primarily comes from product sales in Germany, with additional income from grant agencies in the United States. The company operates through Direct sales and Distributors/strategic partners in United States, Germany and Other Countries. The company's product consists of Cytosorb, ECOS-300CY, VetResQ, HemoDefend, and DrugSorb-ATR.

About LASE Laser Photonics Corporation

Laser Photonics Corp is an integrated manufacturing company for photonics-based industrial products and solutions, primarily laser cleaning technologies. Its laser-blasting technologies are focused on disrupting the sandblasting and abrasives blasting markets. The company offers a portfolio of integrated laser-blasting solutions for corrosion control, rust removal, de-coating, pre-welding and post-welding, laser cleaning, and surface conditioning. Its laser-blasting solutions are applicable in every industry dealing with materials processing, including automotive, aerospace, healthcare, consumer products, shipbuilding, aerospace, machine manufacturing, nuclear maintenance and de-commissioning, and surface coating.

Share on Social Networks: